Delayed Neurologic Syndrome Associated with Carbon Monoxide Poisoning

Erman Altunışık, Ali Zeynel Abidin Tak, Ali Haydar Baykan

DOI: 10.4274/tnd.2020.25874

Issue: 2020, Volume 26 - Issue 3
0 266

Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes

Mehdi Maghbooli, Vida Mohammadzadeh, Mehran Yousefi

DOI: 10.4274/tnd.2020.45467

Issue: 2020, Volume 26 - Issue 2
0 333

Reversible Cranial Magnetic Resonance Imaging Lesions in Status Epilepticus: A Case Report

Sibel Üstün Özek, Cihat Örken, Doğa Coşkun Sönmez, Kemal Harmancı

DOI: 10.4274/tnd.2020.20270

Issue: 2020, Volume 26 - Issue 2
0 414

The Role of Neurologist in the Assessment and Treatment of Depression

Emre Kumral, Fatma Ece Bayam

DOI: 10.4274/tnd.2019.44341

Issue: 2020, Volume 26 - Issue 1
0 294

Investigation of Adaptation to Successive Postural Perturbations in Patients with Multiple Sclerosis

Yeliz Salcı, Ecem Karanfil, Ender Ayvat, Ayla Fil Balkan, Jale Karakaya, Songül Aksoy, Kadriye Armutlu, Aslı Kurne, Rana Karabudak

DOI: 10.4274/tnd.2019.34392

Issue: 2020, Volume 26 - Issue 1
0 275

Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study

Canan Duman İlki, Tuncay Gündüz, Murat Kürtüncü, Zuhal Yapıcı, Serra Sencer, Mefküre Eraksoy

DOI: 10.4274/tnd.2019.77010

Issue: 2020, Volume 26 - Issue 1
0 303

The Value of Autoantibody and Viral Serologic Examinations in the Differential Diagnosis of Multiple Sclerosis and Stroke

Ahmet Şair, Utku Ogan Akyıldız, Berna Korkmazgil, Nefati Kıylıoğlu

DOI: 10.4274/tnd.2019.09735

Issue: 2019, Volume 25 - Issue 4
0 301

Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study

Gülşen Delikanlı Akbay, Erdinç Karakullukçu, Aslı Akyol Mutlu, Halit Tanju Besler

DOI: 10.4274/tnd.2019.33341

Issue: 2019, Volume 25 - Issue 4
0 292

Primary Central Nervous System Lymphoma: Diffuse Large B-Cell Lymphoma

Asuman Ali, Cemile Haki, Fatma Öz Atalay, Ramazan Yalçın

DOI: 10.4274/tnd.2019.41882

Issue: 2019, Volume 25 - Issue 4
0 418

A Patient with Bilateral Subdural Hematoma due to Spontaneous Intracranial Hypotension

Özge Öcek, Levent Öcek

DOI: 10.4274/tnd.2019.73636

Issue: 2019, Volume 25 - Issue 4
0 296

The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis

Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal

DOI: 10.4274/tnd.2019.04207

Issue: 2019, Volume 25 - Issue 3
0 296

Diffusion Tensor Imaging in a Patient with Joubert Syndrome

Mehmet Haydar Atalar, Bülent Yıldız, Özlem Kayım Yıldız

DOI: 10.4274/tnd.2019.90912

Issue: 2019, Volume 25 - Issue 3
0 245

“Face of the Giant Panda” Sign in Wilson Disease

Mehmet Atalar, Nisa Başpınar

DOI: 10.4274/tnd.2019.60863

Issue: 2019, Volume 25 - Issue 3
0 859

Leptomeningeal Carcinomatosis in a Patient with Ovarian Cancer

Özlem Kayım Yıldız

DOI: 10.4274/tnd.2019.43799

Issue: 2019, Volume 25 - Issue 3
0 264

What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance

Ezgi Akyıldız Tezcan, Hakan Ekmekçi, Gökhan Özdemir, Haluk Gümüş, Şerefnur Öztürk

DOI: 10.4274/tnd.2019.93206

Issue: 2019, Volume 25 - Issue 3
0 332

Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?

Bahar Say, Ufuk Ergün

DOI: 10.4274/tnd.2019.87513

Issue: 2019, Volume 25 - Issue 3
0 373

Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes

İpek Güngör Doğan

DOI: 10.4274/tnd.2019.97720

Issue: 2019, Volume 25 - Issue 3
0 277

The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results

Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale

DOI: 10.4274/tnd.2019.75725

Issue: 2019, Volume 25 - Issue 2
0 261

Spinal Subarachnoid Hemorrhage: Case Report

Serhat Yıldızhan

DOI: 10.4274/tnd.2018.46244

Issue: 2019, Volume 25 - Issue 2
0 279

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis

Halil Önder

DOI: 10.4274/tnd.2019.05925

Issue: 2019, Volume 25 - Issue 2
0 237